—

HUTCHMED DRC (HCM) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for HCM, from the same nightly bakes the boards use. Research diary readings, not advice.

Mentioned on Closelooknet 2 pieces · newest: Dossier, “The Agentic Winners 25” (2026-03-31)

Mentioned on Closelooknet

Where HCM appears in the diary — 2 pieces, newest first. Every link is our own writing.

Long reads

101 and glossary

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 47/100 · S&P 500 fund at 43, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-16
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 82th percentile of the window, -8.0% over 20 sessions. Factor regime → 2026-10-16
  • Sovereign pressure Index -0.09 · down 0.09 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-16
How it trades on rate days beta 0.23 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How HCM has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.23 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), HUTCHMED DRC moved 0.23% on average · correlation 0.06 · higher than 18% of US names
  • Beta, last 3 months 0.50 more rate-sensitive lately than over the year
  • On the 10 worst bond days −0.11% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −3.27% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Drug Manufacturers - Specialty & Generic · US · 8 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic · US

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against HCM on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

The Street on this name 2 analyst actions on the wire · latest: upgrade by HSBC, 2026-09-08

The Street on this name

Analyst actions and the latest print for HCM from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Upgrade HSBC — Hold → Buy Upgraded to Buy from Hold 2026-09-08
  • Price target Daiwa — target 18.5 Target set to $18.5 (+31% to spot) 2026-09-03

2 actions on the analyst wire since 2026-08-13: 1 upgrade, 1 target change. Analyst wire → · Earnings wire →

About HUTCHMED DRC

HUTCHMED DRC (HCM) trades on US exchanges.

closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-10-18

Quick answers

What is HUTCHMED DRC (HCM)?

HUTCHMED DRC trades as HCM on the US exchange (US) in the Closelooknet research universe, as of the registry build of 2026-10-18.

Is HCM in a Closelooknet index?

Not currently — HUTCHMED DRC is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-18.

Where does HCM trade against its moving averages?

Uptrend stack intact: Trades +5.4% vs the 50-day and +6.1% vs the 200-day average, 14% below the 52-week high and +43.8% off the 52-week low; a golden cross printed 3 sessions ago. Computed from daily closes. As of 2026-10-16 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does HUTCHMED DRC compare with its peers?

Against its peer group (Drug Manufacturers - Specialty & Generic · US), HUTCHMED DRC (HCM) sits 14.0% below its 52-week high, 5.4% above its 50-day average; Lantheus Holdings Inc (LNTH) is 10.9% below, Kiniksa Pharmaceuticals Ltd (KNSA) is 5.3% below, GALDERMA GROUP AG (GALDY) is 8.4% below. Put any of them next to HCM in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does HUTCHMED DRC trade when bond yields rise?

Over the past year HUTCHMED DRC had a beta of 0.23 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 18% of US names. On the 10 sessions in which long bonds fell most it moved −0.11% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

Where has Closelooknet written about HUTCHMED DRC?

HUTCHMED DRC appears in 2 Closelooknet pieces, most recently Dossier: The Agentic Winners 25 (2026-03-31); 101: Agentic Winners 40: Who Captures AI's Value. What Closelooknet said most recently: The enterprise operating layer: ERP, CRM, HCM, workflow, orchestration. (101). The "Mentioned on Closelooknet" block on this page lists the long reads, the reference entries and the dailies that name it.

What has Wall Street done on HUTCHMED DRC recently?

The most recent analyst action on HUTCHMED DRC on the Closelooknet wire is a upgrade by HSBC on 2026-09-08 (Hold → Buy). 2 actions on the analyst wire since 2026-08-13: 1 upgrade, 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for HCM, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.